| Study |
Reference |
|
Alami, 2017
|
Alami Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie ; 73:199-207
|
|
Andreoli, 2022
|
Andreoli Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals. Clin Rev Allergy Immunol 2022; 62:346-353
|
|
Angelberger, 2011
|
Angelberger Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011; 5:95-100
|
|
Ban (Controls unexposed, disease free), 2014
|
Ban Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology 2014; 146:76-84
|
|
Ban (Controls unexposed, sick), 2014
|
Ban Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology 2014; 146:76-84
|
|
Bröms, 2016
|
Bröms Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment. Scand J Gastroenterol 2016; 51:1462-1469
|
|
Bröms (Crohn’s disease, stable disease), 2014
|
Bröms Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis 2014; 20:1091-8
|
|
Casanova, 2013
|
Casanova Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease. Am. J. Gastroenterol. 2013; 108:433-40
|
|
Cleary (Controls unexposed, NOS), 2009
|
Cleary Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res. Part A Clin. Mol. Teratol. 2009; 85:647-54
|
|
Cleary (Controls unexposed, sick), 2009
|
Cleary Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res. Part A Clin. Mol. Teratol. 2009; 85:647-54
|
|
Coelho (Controls exposed to 5-ASA), 2011
|
Coelho Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2011; 60:198-203
|
|
Coelho (Controls unexposed, sick), 2011
|
Coelho Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2011; 60:198-203
|
|
Colvin, 2010
|
Colvin Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens. 2010; 19:1137-50
|
|
Dejaco, 2005
|
Dejaco Pregnancy and birth outcome under thiopurine therapy for inflammatory bowel disease (IBD). Gastroenterology 2005; 128: A12.
|
|
Francella, 2003
|
Francella The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. 2003; 124:9-17
|
|
Goldstein, 2007
|
Goldstein Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res. Part A Clin. Mol. Teratol. 2007; 79:696-701
|
|
He, 2022
|
He Pregnancy outcomes in Takayasu arteritis patients. Semin Arthritis Rheum 2022; 55:152016
|
|
Howren, 2020
|
Howren Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study. Clin. Exp. Rheumatol. 2020; :
|
|
Jolving, 2021
|
Jølving The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines. Aliment Pharmacol Ther 2021; 54:1061-1069
|
|
Kanis, 2017
|
Kanis Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study. Clin Gastroenterol Hepatol 2017; 15:1232-1241.e1
|
|
Kanis, 2021
|
Kanis Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life. Gut 2021; 70:1266-1274
|
|
Komoto, 2016
|
Komoto Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan. Intest Res 2016; 14:139-45
|
|
Koslowsky, 2019
|
Koslowsky Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant. Dig Dis Sci 2019; 64:2286-2290
|
|
Langagergaard (Controls unexposed, NOS), 2007
|
Langagergaard Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study. Aliment. Pharmacol. Ther. 2007; 25:73-81
|
|
Langagergaard (Controls unexposed, sick), 2007
|
Langagergaard Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study. Aliment. Pharmacol. Ther. 2007; 25:73-81
|
|
Lazzaroni, 2020
|
Lazzaroni Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study. Front Pharmacol 2020; 11:613239 Lazzaroni, M.G. Neuropsychiatric outcome of children born to women with systemic lupus erythematosus (SLE) women and exposed in utero to azathioprine: A case-control study Ann. Rheum. Dis. 2020; 79:1511-.
|
|
Mahadevan, 2021
|
Mahadevan Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology 2021; 160:1131-1139
|
|
Marder, 2013
|
Marder In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013; 65:759-66
|
|
Meyer, 2025
|
Meyer Risks of 75 major congenital malformations after in utero exposure to thiopurines and anti-TNF for maternal inflammatory bowel disease. Clin Gastroenterol Hepatol 2025; :
|
|
Meyer a (Controls exposed to Anti-TNF), 2021
|
Meyer Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor. Clin Gastroenterol Hepatol 2021; :
|
|
Meyer a (Controls unexposed, sick), 2021
|
Meyer Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor. Clin Gastroenterol Hepatol 2021; :
|
|
Meyer b (Controls exposed to Anti-TNF), 2021
|
Meyer Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010–2018. Aliment Pharmacol Ther. 2021 Aug
|
|
Meyer b (Controls unexposed, sick), 2021
|
Meyer Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010–2018. Aliment Pharmacol Ther. 2021 Aug
|
|
Nguyen, 2019
|
Nguyen Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019; 28:235-243
|
|
Nguyen_IBD (Controls exposed to TNFi), 2025
|
Nguyen Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies. Am J Gastroenterol 2025; :
|
|
Nguyen_IBD (Controls unexposed, sick), 2025
|
Nguyen Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies. Am J Gastroenterol 2025; :
|
|
Nguyen_SLE (Controls exposed to TNFi), 2025
|
Nguyen Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies. Am J Gastroenterol 2025; :
|
|
Nguyen_SLE (Controls unexposed, sick), 2025
|
Nguyen Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies. Am J Gastroenterol 2025; :
|
|
Norgard, 2020
|
Nørgård In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark. 2020; 52:829-842
|
|
Norgard (Controls unexposed, NOS), 2003
|
Nørgård Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment. Pharmacol. Ther. 2003; 17:827-34
|
|
Norgard (Controls unexposed, sick), 2003
|
Nørgård Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment. Pharmacol. Ther. 2003; 17:827-34
|
|
Reynolds, 2022
|
Reynolds Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine. Rheumatology (Oxford) 2022; :
|
|
Schramm, 2006
|
Schramm Pregnancy in autoimmune hepatitis: outcome and risk factors. 2006; 101:556-60
|
|
Selinger (Controls unexposed, disease free), 2023
|
Rosiou, K. Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy J. Crohn's Colitis 2023; 17:i626-. Selinger Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy. Expert Opin Drug Saf 2023; 22:1091-1097
|
|
Selinger (Controls unexposed, sick), 2023
|
Rosiou, K. Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy J. Crohn's Colitis 2023; 17:i626-. Selinger Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy. Expert Opin Drug Saf 2023; 22:1091-1097
|
|
Shim, 2011
|
Shim The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 2011; 5:234-8
|
|
Tennenbaum, 1999
|
Tennenbaum Pregnancy outcome in inflammatory bowel disease. Gastroenterol Clin Biol, 1999, 23, 564-569.
|
|
Vestergaard, 2024
|
Vestergaard Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD. Inflamm Bowel Dis 2024; 30:2297-2305
|
|
Viktil (Controls exposed to other treatments), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Viktil (Controls unexposed, NOS), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Yeaman (Controls mainly exposed to biologics), 2023
|
Yeaman Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD. Crohns Colitis 360 2023; 5:otad066
|
|
Yeaman (Controls unexposed, disease free), 2023
|
Yeaman Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD. Crohns Colitis 360 2023; 5:otad066
|
